1821P A multicentre analysis of toxicity in 6 weekly vs 3 weekly pembrolizumab dosing
- Resource Type
- Source
- Annals of Oncology. 31:S1050-S1051
- Subject
Oncology medicine.medical_specialty business.industry Internal medicine Toxicity medicine Hematology Dosing Pembrolizumab business - Language
- ISSN
- 0923-7534